PRIMARY PERITONEAL CAVITY CANCER
Clinical trials for PRIMARY PERITONEAL CAVITY CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CAVITY CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CAVITY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy targets hard-to-treat ovarian cancers
Disease control Recruiting nowThis early-stage trial is testing whether a modified immune cell therapy called FT536 can help control recurrent ovarian, fallopian tube, or primary peritoneal cancers. Participants receive chemotherapy followed by FT536 delivered directly into the abdomen through a temporary cat…
Matched conditions: PRIMARY PERITONEAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New weapon against tough cancers enters first human tests
Disease control Recruiting nowThis is the first study in people to test a new drug called XMT-1660 for several types of advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects it causes. Researchers will also look for early signs that the drug can s…
Matched conditions: PRIMARY PERITONEAL CAVITY CANCER
Phase: PHASE1 • Sponsor: Mersana Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New drug combo targets tough ovarian cancers
Disease control Recruiting nowThis study is testing whether two drugs, Senaparib and Temozolomide, work together to shrink tumors in women with recurrent clear cell or endometrioid ovarian, fallopian tube, or primary peritoneal cancers that have a specific genetic change called an ARID1A mutation. The trial i…
Matched conditions: PRIMARY PERITONEAL CAVITY CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC